Detection of neurofilament-H in serum as a diagnostic tool to predict injury severity in patients who have suffered mild traumatic brain injury.

  title={Detection of neurofilament-H in serum as a diagnostic tool to predict injury severity in patients who have suffered mild traumatic brain injury.},
  author={Joshua W. Gatson and Jennifer Barillas and Linda S. Hynan and Ramon Diaz-Arrastia and Steven E. Wolf and Joseph P. Minei},
  journal={Journal of neurosurgery},
  volume={121 5},
OBJECT In previous studies of traumatic brain injury (TBI), neural biomarkers of injury correlate with injury severity and predict neurological outcome. The object of this paper was to characterize neurofilament-H (NFL-H) as a predictor of injury severity in patients who have suffered mild TBI (mTBI). Thus, the authors hypothesized that phosphorylated NFL-H (pNFL-H) levels are higher in mTBI patients than in healthy controls and identify which subjects experienced a more severe injury such as… 

Figures and Tables from this paper

Serum neurofilament light protein predicts clinical outcome in traumatic brain injury

Data suggests that measurement of serum NF-L may be useful to assess the severity of neuronal injury following sTBI, and compares the diagnostic and prognostic utility ofNF-L with the established blood biomarker S100B.

The Serum Phosphorylated Neurofilament Heavy Subunit as a Predictive Marker for Outcome in Adult Patients after Traumatic Brain Injury.

The results of this study indicate that the serum pNF-H value is a useful predictive marker for patient outcome after TBI.

Serial changes in serum phosphorylated neurofilament and value for prediction of clinical outcome after traumatic brain injury

The temporal profile of blood p NF-H seems to be useful to predict the clinical outcome after TBI, and the peak pNF-H value was correlated with clinical outcomeAfter TBI.

Derivation of a Three Biomarker Panel to Improve Diagnosis in Patients with Mild Traumatic Brain Injury

Objective blood tests, detecting NRGN, NSE, and MT3, can be used to identify mTBI, irrespective of neuroimaging findings, andhyperacute testing is possible with these biomarker assays.

A New Panel of Blood Biomarkers for the Diagnosis of Mild Traumatic Brain Injury/Concussion in Adults.

This panel of biomarkers discerns, with high accuracy, patients with isolated concussion from uninjured individuals within the first 8 h after accident, and can also aid in diagnosing concussion in the presence of OI.

A New Panel of Blood Biomarkers for the Diagnosis of Mild Traumatic Brain Injury/Concussion in Adults

Four candidate biomarker proteins whose synthesis is altered post-mTBI and whose blood levels could be measured using standard immunoassays were identified: copeptin; galectin 3 (LGALS3); matrix metalloproteinase 9 (MMP9); and occludin (OCLN).

Review of the potential use of blood neuro-biomarkers in the diagnosis of mild traumatic brain injury

Based on the available evidence, the most promising neuro-biomarkers appear to be Glial fibrillary acidic protein and Ubiquitin C-Terminal Hydrolase Isozyme L1 (UCH-L1) as these show significant rises in peripheral blood levels shortly after injury and these have been demonstrated to correlate with long-term clinical outcomes.

Prognosis and Diagnostic Biomarkers of Mild Traumatic Brain Injury: Current Status and Future Prospects.

The role of biomarkers as potential key factors in diagnosing mTBI is discussed, with a focus on protein based peripheral and CNS markers, genetic biomarkers, imaging biomarker, and neurophysiological biomarkers.

Current status of fluid biomarkers in mild traumatic brain injury

Early versus Late Profiles of Inflammatory Cytokines after Mild Traumatic Brain Injury and Their Association with Neuropsychological Outcomes

Plasma cytokine levels (within 24h and at 6 months post-injury) were significantly associated with early and late post-concussive symptoms, PTSD, and depression scores after mTBI, highlighting the potential role of inflammation in the pathophysiology of post-traumatic symptoms aftermTBI.



The Challenge of Mild Traumatic Brain Injury: Role of Biochemical Markers in Diagnosis of Brain Damage

This review discusses the current research on serum biomarkers for mTBI including their rationale and diagnostic performances and outlines the roles of biomarkers in settings of specific interest including pediatric TBI, sports concussions and military injuries.

Hyperphosphorylated neurofilament NF-H as a predictor of mortality after brain injury in children

Findings suggest that levels of hyperphosphorylated neurofilament NF-H correlate with mortality and may be useful as predictors of outcome in children with TBI.

S100B serum level predicts computed tomography findings after minor head injury.

Determination of serum S100B cannot replace the clinical examination or use of CT for patients with minor head injury, but adding S 100B measurement to the clinical evaluation might support selection of patients for CT scanning.

GFAP versus S100B in serum after traumatic brain injury: relationship to brain damage and outcome.

Both measurement of GFAP and S100B is a useful non-invasive means of identifying brain damage with some differences based on the pattern of TBI and accompanying multiple trauma and/or shock.

The usefulness of S100B, NSE, GFAP, NF-H, secretagogin and Hsp70 as a predictive biomarker of outcome in children with traumatic brain injury

Findings suggest that levels of biomarkers correlate with mortality and may be useful as predictors of outcome in children with TBI.

The clinical value of serum S-100 protein measurements in minor head injury: a Scandinavian multicentre study.

Undetectable serum level of S-100 protein predicts normal intracranial findings on CT scan and may be more related to post-concussion symptoms caused by mild traumatic brain injury than to symptoms of psychological origin.

A panel of neuron-enriched proteins as markers for traumatic brain injury in humans.

The results identify neuron-enriched proteins that may serve as a panel of CSF and blood surrogate markers for the minimally invasive detection, management, mechanistic, and therapeutic evaluation of human TBI.

Clinical Significance of αII-Spectrin Breakdown Products in Cerebrospinal Fluid after Severe Traumatic Brain Injury

Levels of spectrin breakdown products (SBDPs) in cerebrospinal fluid (CSF) from adults with severe TBI are examined and the relationship between these levels, severity of injury, and clinical outcome is examined.

Elevated serum S-100B protein as a predictor of failure to short-term return to work or activities after mild head injury.

In MHI, the elevated S-100B seemed to correlate with an unfavorable short-term outcome, which might be useful in selecting patients who need closer observation, hospitalization, and further investigations (such as CT scan or MRI), and the prognosis of genuine post-concussion symptoms, that interfere with return to work or activities.